NASDAQ:BPMC - Blueprint Medicines Corporation
$95.92
 $0.93
+0.98%
4:00PM EDT
2019-07-15
Blueprint Medicines Corporation is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. It focuses on crafting drug candidates that provide clinical responses to patients without adequate treatment options. It has developed a small molecule drug pipeline in cancer and a genetic disease. Its drug candidate, BLU-285, targets KIT, including Exon 17 mutations, and targets PDGFRa, including the D842V mutation. These mutations activate receptor tyrosine kinases that are drivers of cancer and proliferative disorders, including gastrointestinal stromal tumors (GIST), and systemic mastocytosis (SM). Its drug candidate BLU-554 targets FGFR4, a kinase that is activated in a defined subset of patients with hepatocellular carcinoma (HCC), the common type of liver cancer. It is engaged in developing BLU-667, a drug candidate that targets RET, a receptor tyrosine kinase that is activated by mutations or translocations. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BPMC     avg for
industry  
  avg for
sector  
42 stocks weight:  133. 63   114. 77   204. 78  
42 stocks rank:  1. 09 K 1. 44 K 810. 33  
# analyst opinions:  8. 00   13. 59   13. 86  
mean recommendation:  1. 40   2. 12   2. 04  

quick ratio:  6. 42   5. 48   1. 89  
current ratio:  6. 59   5. 85   2. 40  

target price low:  103. 00   82. 72   115. 11  
target price avg:  112. 13   104. 42   138. 02  
target price high:  128. 00   130. 64   159. 47  
1-yr high:  98. 49   110. 27   142. 72  
last close:  94. 99   85. 12   126. 54  
50-day avg:  86. 55   86. 06   122. 35  
200-day avg:  73. 56   88. 76   121. 75  
1-yr low:  45. 57   69. 26   100. 63  
volume:  310. 96 K 3. 51 M 5. 53 M
50-day avg volume:  515. 51 K 3. 21 M 4. 22 M
200-day avg volume:  438. 51 K 3. 04 M 4. 75 M

1-day return:  0. 96 % -0. 30 % -1. 01 %
this week return:  -0. 84 % -2. 16 % -1. 35 %
12-wk return:  28. 63 % 3. 34 % 8. 69 %
52-wk return:  45. 59 % -1. 76 % 12. 22 %

enterprise value (EV):  4. 39 B 46. 50 B 123. 99 B
market cap:  4. 60 B 40. 77 B 109. 11 B
EBITDA:  -272. 50 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -16. 09   5. 45   12. 05  
enterprise/revenue (EV/R):  99. 01   50. 46   9. 50  
total revenue:  44. 30 M 10. 21 B 40. 60 B
total debt:  99. 60 M 11. 27 B 17. 58 B
debt/equity:  28. 94   57. 36   120. 25  
net income (common):  -267. 50 M 2. 13 B 4. 27 B

shares outstanding:  43. 84 M 551. 08 M 1. 24 B
shares:  48. 20 M 559. 41 M 1. 22 B
shares short:  2. 64 M 11. 15 M 11. 94 M
shares short prior month:  2. 38 M 9. 31 M 11. 96 M
short ratio:  5. 02   5. 72   3. 43  
short % of float:  7. 11 % 6. 40 % 2. 65 %
total cash/share:  8. 51   11. 00   9. 23  
total cash:  415. 86 M 6. 03 B 6. 01 B
free cash flow:  -122. 76 M 3. 02 B 4. 96 B
operating cash flow:  -205. 63 M 3. 92 B 5. 99 B

book value:  7. 79   13. 02   27. 49  
price/book:  12. 19   4. 21   8. 80  
gross profits:  -199. 10 M 7. 67 B 36. 29 B
operating margins:  -628. 01 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  13. 96 % --- ---
1-yr mean volatility:  2. 64 % 1. 50 % 1. 08 %

1-yr EPS:  -6. 08   2. 12   4. 26  
forward EPS:  -7. 97   3. 47   7. 14  
P/E:  -15. 61   2. 15   33. 17  
forward P/E:  -12. 14   -4. 03   17. 60  
PE/G:  0. 66   0. 54   0. 34  
growth:  -23. 50 % 263. 03 % 78. 34 %
earnings high:  -1. 48   0. 91   1. 70  
earnings avg:  -1. 84   0. 71   1. 58  
earnings low:  -2. 03   0. 48   1. 46  
revenue high:  6. 50 M 2. 64 B 11. 26 B
revenue avg:  2. 14 M 2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -28. 76 % -2. 31 % 5. 31 %
return on equity:  -58. 46 % -82. 48 % 135. 30 %
revenue growth:  -23. 50 % 262. 60 % 72. 94 %
revenue/share:  1. 01   12. 77   61. 38  

beta (1yr vs S&P500):  1. 96   1. 26   0. 91  
sharpe (1yr):  0. 90   0. 07   0. 77  

held % insiders:  1. 45 % 6. 08 % 3. 31 %
held % institutions:  95. 00 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : BPMC
.    145.247 =       145.247 :: --> INITIAL WEIGHT <--
.    - 6.084 =       139.163 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.323 =       323.293 :: P/E factor
.    x 1.108 =       358.089 :: PE/G factor
.     x 1.41 =       504.946 :: beta factor
.    x 0.964 =       486.538 :: sharpe factor
.    x 2.875 =      1398.754 :: current ratio factor
.    x 1.088 =      1522.309 :: quick ratio factor
.    x 1.095 =      1667.053 :: short ratio factor
.    x 1.038 =      1730.108 :: EV/R factor
.    x 1.123 =      1943.054 :: price-to-book factor
.    x 0.798 =      1551.009 :: debt-to-revenue factor
.    x 1.227 =      1902.427 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      4021.702 :: sector+industry 1-year gains factor
.    x 1.033 =      4156.019 :: industry 12-weeks return factor
.    x 1.305 =      5424.742 :: industry 2-weeks return factor
.    x 1.417 =      7687.546 :: company one-year gains+dividend factor
.    x 3.418 =     26272.558 :: company 13 weeks' performance factor
.    x 1.596 =     41940.452 :: 5-day avg > 200-day avg
.    x 1.434 =     60140.228 :: 5-day avg > 50-day avg
.    x 1.177 =     70761.741 :: 50-day avg > 200-day avg
.    x 0.981 =     69426.365 :: "drift" penalty 4 days ago
.    / 1.992 =     34861.145 :: overall "drift" factor
.    x 0.877 =     30572.708 :: largest single-day jump factor
.     x 0.99 =     30279.755 :: volatility factor
.     x 0.99 =     29971.506 :: 42-day volatility factor
.    x 4.754 =    142477.789 :: notable returns + performance factor
.    x 3.571 =    508848.648 :: performance vs s&p500 factor
.    x 3.584 =   1823855.902 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.516 =    941992.461 :: forward EPS factor
.    x 0.824 =    776484.254 :: forward P/E factor
.    x 1.182 =    918152.918 :: industry recommendation factor
.    x 3.221 =     2957076.5 :: company recommendation factor
.    x 1.008 =   2979693.231 :: factor historical industry gain for week 28
.     x 1.36 =    4053242.32 :: target low factor
.    x 1.142 =    4627157.63 :: target mean factor
.    x 1.025 =   4741721.433 :: target high factor
.   x 10.185 =  48296751.028 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        83.364 :: reduced for readability
.   + 48.664 =       132.028 :: add/subtract for investor sentiment
.    + 1.606 =       133.634 :: earnings report in 15 days
.                               --> FINAL WEIGHT <--
.                    133.634 :: FINAL WEIGHT for NASDAQ:BPMC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org